| Literature DB >> 19695477 |
Karl Lintner1, Claire Mas-Chamberlin, Philippe Mondon, Olivier Peschard, Louis Lamy.
Abstract
Cosmetic ingredients previously considered "inert" have potential to provide a biologic effect to skin. In a cosmeceutical formulation, the boundary between an "active" and "inert" ingredient may be obscured. For this reason, the cosmeceutical distributor must find a nonambiguous method to demonstrate the efficacy of a new ingredient. For a product to be successful in the marketplace, the benefits of the product must clearly be communicated to the consumer, and the consumer must be satisfied with product performance.Mesh:
Substances:
Year: 2009 PMID: 19695477 DOI: 10.1016/j.clindermatol.2009.05.009
Source DB: PubMed Journal: Clin Dermatol ISSN: 0738-081X Impact factor: 3.541